documents: FDA-2003-N-0196-0047
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | agency_id | docket_id | title | document_type | subtype | posted_date | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2003-N-0196-0047 | FDA | FDA-2003-N-0196 | Letter from Buchanan Ingersoll to the Division of Over-The-Counter Drug Products, July 25, 2003 | Other | Letter(s) | 2014-06-09T04:00:00Z | 2014 | 6 | 2014-06-09T04:00:00Z | 2014-06-09T21:12:37Z | 0 | 0 | 090000648048b600 |
Links from other tables
- 0 rows from regs_document_id in fr_regs_crossref